Physician profile
John Zobian
NPI 1114586724
$450.57
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $20.22 · 2022: $35.41 · 2023: $395.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $395.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $394.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Idorsia Pharmaceuticals US INC | $140.74 | 2023 | Quviviq |
| Lilly USA, LLC | $111.84 | 2023 | Mounjaro, Trulicity |
| Novo Nordisk INC | $37.83 | 2022-2023 | Ozempic, Rybelsus |
| Janssen Pharmaceuticals, INC | $34.98 | 2023 | Xarelto |
| Amgen INC. | $27.75 | 2022-2023 | Evenity, Prolia |
| Merck Sharp & Dohme LLC | $21.59 | 2023 | Belsomra, Januvia, Steglatro |
| Exact Sciences Corporation | $20.44 | 2023 | Cologuard Collection Kit |
| Viiv Healthcare Company | $20.22 | 2021 | |
| Dexcom, INC. | $18.11 | 2023 | Dexcom G6 Transmitter |
| Astrazeneca Pharmaceuticals LP | $17.07 | 2023 | Farxiga |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Zobian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.